Authors' reply

Affiliations

¹ Dan Siskind, Metro South Addiction and Mental Health Services, Brisbane, and Melbourne Health, Melbourne, Victoria, Australia. Email: d.siskind@uq.edu.au; Lara McCartney, Melbourne Health, Melbourne, Victoria, Australia; Steve Kisely, Metro South Addiction and Mental Health Services, Brisbane, and University of Queensland School of Medicine, Brisbane, Australia.

Comment

Dan Siskind et al. Br J Psychiatry. 2017 Apr.

. 2017 Apr;210(4):299-300.

doi: 10.1192/bjp.210.4.299a.

¹ Dan Siskind, Metro South Addiction and Mental Health Services, Brisbane, and Melbourne Health, Melbourne, Victoria, Australia. Email: d.siskind@uq.edu.au; Lara McCartney, Melbourne Health, Melbourne, Victoria, Australia; Steve Kisely, Metro South Addiction and Mental Health Services, Brisbane, and University of Queensland School of Medicine, Brisbane, Australia.

No abstract available

Comment on

Clozapine v. first- and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis.
Siskind D, McCartney L, Goldschlager R, Kisely S. Siskind D, et al. Br J Psychiatry. 2016 Nov;209(5):385-392. doi: 10.1192/bjp.bp.115.177261. Epub 2016 Jul 7. Br J Psychiatry. 2016. PMID: 27388573
Clozapine in treatment-resistant schizophrenia.
Samara M, Leucht S. Samara M, et al. Br J Psychiatry. 2017 Apr;210(4):299. doi: 10.1192/bjp.210.4.299. Br J Psychiatry. 2017. PMID: 28373226 No abstract available.